First published on 04 Apr 2017
BSG guidance on the use of intravenous hyoscine butylbromide (buscopan) during gastrointestinal endoscopy
The MHRA has recently circulated a Drug Safety Update regarding the risk of serious adverse events following the use of intravenous Hyoscine Butylbromide (Buscopan) in patients with underlying cardiac disease. Buscopan is commonly used during endoscopic procedures. It induces smooth […]